ctrl K

Price Alert

Kalaris Therapeutics Inc (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

3.08

0.52 (20.31%)

At close: Aug 27, 2025, 3:59 PM

3.08

0.00%

After-hours: Aug 27, 2025, 06:23 PM EDT

Kalaris Therapeutics Inc Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q3 2024	Q4 2023
Period Ending	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Dec 31, 2023
Cash & Equivalents	88.43M	100.97M	1.91M	3.17M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.19M	910K	314K	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	228K	695K	n/a	n/a
Total Current Assets	91.65M	102.18M	2.15M	3.33M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.19M	910K	314K	n/a
Total Assets	92.84M	103.09M	2.46M	3.33M
Account Payables	3.68M	2.37M	2.23M	2.36M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	9.25M	n/a
Other Current Liabilities	686K	602K	1.72M	540K
Total Current Liabilities	7.65M	7.14M	13.77M	3.94M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	32.08M	32.08M	78.08M	44.41M
Total Long-Term Liabilities	32.08M	32.08M	78.08M	44.41M
Total Liabilities	39.73M	39.22M	91.84M	48.35M
Total Debt	n/a	n/a	9.25M	n/a
Common Stock	2K	2K	n/a	n/a
Retained Earnings	-138.11M	-126.76M	-94.53M	-47.39M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	53.12M	63.87M	-89.38M	-45.02M
Total Investments	n/a	n/a	n/a	n/a